Symbol
RSLS on Nasdaq
Investment type
Equity / Common Stock, par value $0.001 per share
Latest Disclosed Shares Owned
200,000 shares
Security Ownership %
6.1%

Leonite Fund I, LP ownership in ReShape Lifesciences Inc. Common Stock, par value $0.001 per share (RSLS)

24 Feb 2025 - Leonite Fund I, LP has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 200,000 shares of ReShape Lifesciences Inc. Common Stock, par value $0.001 per share (RSLS). This represents 6.1% ownership of the company. This is the first filing by Leonite Fund I, LP disclosing ownership of ReShape Lifesciences Inc. Common Stock, par value $0.001 per share (RSLS).